Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
暂无分享,去创建一个
P. Delmas | D. Karpf | P. Garnero | E. Gineyts | W. Shih | P. Delmas
[1] A. Parfitt. The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. , 1982, Metabolic bone disease & related research.
[2] J. Risteli,et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. , 1993, Clinical chemistry.
[3] J. Pødenphant,et al. Bone turnover in spinal osteoporosis , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] E. Opas,et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. , 1993, The Journal of clinical investigation.
[5] S. Cummings,et al. Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women , 1991 .
[6] D. Uebelhart,et al. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. , 1990, Bone and mineral.
[7] P. D. Bewsher,et al. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. , 1991, The Journal of clinical endocrinology and metabolism.
[8] P. Delmas,et al. Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] J. Risteli,et al. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. , 1990, Clinical chemistry.
[10] T. Inoue,et al. Analysis of pyridinoline, a cross-linking compound of collagen fibers, in human urine. , 1983, Journal of biochemistry.
[11] J. Stepan,et al. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. , 1987, Bone.
[12] P. Kelly,et al. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. , 1972, The Journal of clinical investigation.
[13] David W. Bates,et al. CLINICAL USE OF BONE DENSITOMETRY , 1991 .
[14] J. Reginster,et al. PREVENTION OF POSTMENOPAUSAL BONE LOSS BY TILUDRONATE , 1989, The Lancet.
[15] C. Christiansen,et al. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women , 1988, European journal of clinical investigation.
[16] K. Mann,et al. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. , 1988, The Journal of clinical endocrinology and metabolism.
[17] P. Delmas,et al. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. , 1993, The Journal of clinical endocrinology and metabolism.
[18] L. Mosekilde,et al. Effects of a combined estrogen‐gestagen regimen on serum levels of the carboxy‐terminal propeptide of human type I procollagen in osteoporosis , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] D. Eyre,et al. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] W. O'Fallon,et al. Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] M. Kleerekoper,et al. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. , 1983, The Journal of clinical investigation.
[22] H. Genant,et al. The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. , 1993, The Journal of clinical endocrinology and metabolism.
[23] P. Delmas,et al. Measurement of serum osteocalcin with a human‐specific two‐site immunoradiometric assay , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] B. Smedsrød,et al. Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. , 1990, The Biochemical journal.
[25] S. Robins,et al. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. , 1988, Analytical biochemistry.
[26] K. Mann,et al. Effect of renal function on plasma levels of bone Gla-protein. , 1983, The Journal of clinical endocrinology and metabolism.
[27] E. Eriksen,et al. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. , 1986, Endocrine reviews.
[28] H. Rosen,et al. Immunoassay for urinary pyridinoline: The new marker of bone resorption , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] C. Christiansen,et al. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.